Pre-eclampsia and the vascular endothelial growth factor: A new aspect

Clinical and Experimental Obstetrics and Gynecology

Volumn 43, Issue 1, 2016, Pages 9-13

  Liberis, A ^a   Stanulov, G ^a   Chafouz Ali, E ^a   Hassan, A ^a   Pagalos, A ^a   Kontomanolis, E N ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Cytotrophoblast; Gestational hypertension; Hypertension; Pre eclampsia; Pregnancy; VEGF

Indexed keywords

VASCULOTROPIN; BIOLOGICAL MARKER; VASCULOTROPIN A;

ANGIOGENESIS; CARCINOGENESIS; GENE; GENETIC POLYMORPHISM; HUMAN; OVARY CYCLE; PATHOPHYSIOLOGY; PREECLAMPSIA; REVIEW; VASCULOTROPIN GENE; BLOOD; FEMALE; METABOLISM; PREGNANCY; VASCULAR ENDOTHELIUM;

BIOMARKERS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84960892707     PISSN: 03906663     EISSN: 27090094     Source Type: Journal    
DOI: 10.12891/ceog2057.2016     Document Type: Review

References (34)

1. Mutter W. P., Karumanchi A.: "Molecular mechanisms of preeclampsia". Microvasc. Res., 2008, 75, 1. Epub 2007 May 6.
2. Taki A., Abe A., Komaki M., Oku K., Iseki S., Mizutani S., Morita I.: "Expression of angiogenesis-related factors and inflammatory cytokines in placenta and umbilical vessels in pregnancies with preeclampsia and chorioamnionits/funisitis". Congenit. Anom. (Kyoto), 2012, 52, 97. doi: 10.1111/j.1741-4520.2012.00359.x..
3. Davison J. M., Homuth V., Jeyabalan A., Conrad K. P., Karumanchi S. A., Quaggin S., et al.: "New aspects in the pathophysiology of preeclampsia". J. Am. Soc. Nephrol., 2004, 15, 2440.
4. Page N. M., Dakour J., Morrish D. W.: "Gene regulation of neurokinin B and its receptor NK3 in late pregnancy and pre-eclampsia". Mol. Hum. Reprod., 2012, 12, 427. Epub 2006 May 18.
5. Berkane N., Lefevre G., Hertig A.: "Angiogenic factors in preeclampsia: so complex, so simple? ", Nephrol. Dial., Transplant, 2007, 22, 2753. Epub 2007 Jul. 7.
6. Grill S., Rusterholz C., Zanetti-Dällenbach R., Tercanli S., Holzgreve W., Hahn S., Lapaire O.: " Potential markers of preeclampsiaa review". Reprod. Biol. Endocrinol., 2009, 7, 70.
7. Wang Y., Alexander J. S.: "Placental pathophysiology in preeclampsia". Pathophysiol., 2000, 6, 261.
8. Boite A. C., van Geijn H. P., Dekker G. A.: "Pathophysiology of preeclampsia and the role of serotonin". Eur. J. Obstet. Gynecol. Reprod. Biol., 2001, 95, 12.
9. Harrington L. S, Sainson R. C., Williams C. K., Taylor J. M., Shi W., Li JL., Harris A. L.: "Regulation of multiple angiogenic pathways by DII4 and Notch in human umbilical vein endothelial cells". Microvasc. Res., 2008, 75, 144. Epub 2007 Jun. 29.
10. Staff A. C., Harsem N. K., Braekke K., Hyer M., Hoover R. N., Troisi R.: "Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies". Eur. J. Obstet. Gynecol. Reprod. Biol., 2009, 143, 29. Epub 2009 Jan 8.
11. Cudihy D., Lee R. V.: "The pathophysiology of pre-eclampsia: Current clinical concepts". J. Obstet. Gynecol., 2009, 29, 576.
12. Lohela M., Bry M., Tammela T., Alitalo K.: "VEGFs and receptors involved in angiogenesis versus lymphangiogenesis". Cun: Opin. Cell. Biol., 2009, 21, 154. Epub 2009 Feb. 21.
13. Bányász I., Szabó S., Bokodi G., Vannay A., Vásárhelyi B., Szabó A., et al.: "Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia". Mol. Hum. Reprod., 2006, 12, 233. Epub 2006 Mar. 3.
14. Shim J. Y., Jun. J. K., Jung B. K., Kim S. H., Won H. S, Lee P. R, Kim A.: "Vascular endothelial growth factor gene +936 C/T polymorphism is associated with preeclampsia in Korean women". Am. J. Obstet. Gynecol., 2007, 197, 271. e1.
15. Regnault T. R. H., Orbus R. J, de Vrijer B., Davidsen M. L., Galan H. L., Wilkening R. B., Anthony R. V.: "Placental expression of VEGF, PIGF and their receptors in a model of Placental Insufficiency-Intrauterine growth restriction (PI-IUGR) ". Placenta, 2002, 23, 132.
16. Gotsch F., Romero R., Kusanovic J. P., Chaiworapongsa T., Dombrowski M., Erez O., et al.: "Preeclampsia and small for gestational age are associated with decreased concentrations of a factor involed in angiogenesis: Soluble tie-2". J. Matern. Fetal Neonatal. Med., 2008, 21, 389. doi: 10.1080/14767050802046069.
17. Sandrim V. C., Palei A. C. T., Cavalli R. C., Araújo F. M., Ramos E. S., Duarte G., Tanus-Santos J. E.: "Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension". Mol. Hum. Reprod., 2009, 15, 115. Epub 2008 Dec. 5..
18. Myatt L., Webster R. P.: "Vascular biology of preeclampsia". J. Thromb. Haemostat., 2009, 7, 375.
19. Gasperowisz M., Otto F.: "The Notch Signaling Pathway in the Development of the Mouse Placenta". Placenta, 2008, 29, 651. Epub 2008 Jul. 7.
20. Papazoglou D., Galazios G., Koukourakis M. I., Panagopoulos I., Kontomanolis E. N., Papatheodorou K., Maltezos E.: "Vascular endothelial growth factor gene polymorphisms and pre-eclampsia". Mol. Hum. Reprod., 2004, 10, 321. Epub 2004 Mar. 2.
21. Holston A. M., Qian C., Yu K. F., Epstein F. H., Karumanchi S. A, Levine R. J.: Circulation angiogenic factors in gestational proteinuria without hypertension". Am. J. Obstet. Gynecol., 2009, 200, 392. el. Epub 2009 Jan 24.
22. Hellström M., Li-Kun Phng., Gerhardt H.: "VEGF and Notch signaling: the yin and yang of angiogenic sprouting". Cell. Adh. Migr., 2007, 1, 133. Epub 2007 Jul. 30.
23. Herr F., Schreiner I., Baal N., Pfarrer C., Zygmunt M.: "Expression patterns of Notch receptors and their ligands Jagged and Delta in human placenta". Placenta, 2011, 32, 554. Epub 2011 Jul. 2.
24. Ahmed A., Dunk C., Ahmad S., Khaliq A.: "Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen-A review". Placenta, 2000, 21, S16.
25. Red-Horse K., Crawford Y., Shojaei F., Ferrara N.: "Endotheliummicroenvironment interactions in the developing embryo and in the adult". Dev. Cell., 2007, 12, 181.
26. Nagy J. A., Dvorak A. M., Dvorak H. F.: "VEGF-A# c164/165 and PIGF: Roles in angiogenesis and arteriogenesis". Trends Cardiovasc. Med., 2003, 13, 169.
27. Erez O., Romero R., Espinoza J., Wenjiang F., Todem D., Kusanovic J. P., et al.: "The change in concentrations of angiogeenic and antiangiogenic factors in maternal plasma between first and second trimesters in risk assessment for the subsequent development of preeclampsia and SGA". J. Matern. Fetal Neonatal Med., 2008, 21, 279.
28. Bdolah Y., Karumanchi S. A., Sachs B. P.: "Recent advances in understanding of preeclampsia". Croat. Med. J., 2005, 46, 728.
29. Hunkapiller N. M., Gasperowicz M., Kapidzic M., Plaks V., Maltepe E., Kitajewski J., et al.: "A role for notch signaling in trophoblast endovascular invasion and in the pathogenesis of pre-eclampsia". Development, 2011, 138, 2987.
30. Foidart J. M., Schaaps J. P., Chantraine F., Munaut C., Lorquet S.: "Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer". J. Reprod. Immunol., 2009, 82, 106, Epub 2009 Oct. 23.
31. Clauss M.: "Function of the VEGF receptor-1 (FLT-1) in the vasculature". Trends Cardiovasc. Med., 1998, 8, 241.
32. Maynard S. E., Min J. Y., Merchan J., Lim K. H., Li J., Mondai S., et al.: "Excess placental soluble fms-like tyrosine kinase 1 (sFltl) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia". J. Clin. Invest., 2003, 111, 649.
33. Ballermann B. J.: "Glomerular endothelial cell differentiation". Kidney Int., 2005, 67, 1668
34. Kusanovic J. P., Romero R., Chaiworapongsa T., Erez O., Mittal P., Vaisbuch E., et al.: "A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the indendification of patients destined to develop preeclampsia". J. Matern. Fetal Neonatal. Med., 2009, 22, 1021.